Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $4.13 billion versus the consensus estimate of $4.07 billion.

Medtronic, Inc. reaffirmed FY2011 guidance.

Earnings Guidance